AstraZeneca $2 billion 2.375% and 3.125% notes issues

13/6/2017
Investment grade bond/note issue

$ 2 billion

Announced

13/6/2017


Overview:

  • AstraZeneca has issued $2 billion in senior notes.
  • The issuance consisted of $1 billion 2.375% notes due 2022, $750 million 3.125% notes due 2027 and $250 million floating-rate notes due 2022.
  • AstraZeneca is a global, innovation-driven bio-pharmaceutical business.

Katrin Kostadinova - Data analyst

Jurisdiction:

United States

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences


Firm:

Party: AstraZeneca (Issuer)